Blood Clots, Health, Health policy

Direct to consumer thrombophilia testing approved–a good thing?

On April 6, 2017, the FDA  approved marketing of 23andMe Personal Genome Service Genetic Health Risk tests for 10 diseases or conditions.(FDA Press Release 4-6-17) No prescription or physician needed. These are the first direct-to-consumer tests authorized by the FDA that provide information on an individual’s genetic predisposition to certain medical conditions.  Among them, hereditary… Continue reading Direct to consumer thrombophilia testing approved–a good thing?

Blood Clots, Health policy, Politics

Fighting for Blood Clot Patients?

I want to like Hillary Clinton.  I do. I'd love to see a female president one day. It's just that every time I see and hear the Hillary Clinton campaign slogan “Fighting for Us”, I can’t help but think of the one population Clinton is not fighting for:   her fellow patients at risk for venous… Continue reading Fighting for Blood Clot Patients?

Blood Clots, Health, Health policy

When the sun doesn’t shine for patients: the glaring loophole in the Sunshine Act

There's a big loophole in the laws governing the reporting of payments by drug companies to clinicians. How it is influencing care for those taking the #1 medication causing adverse drug events.